Politics Jul 09

First intravenous infusion of Aduhelm, Biogen's controversial recently approved drug for early Alzheimer's disease
FDA head calls for probe into Alzheimer’s drug review

Dr. Janet Woodcock announced the extraordinary step via Twitter. It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.

Jan 21

FDA approves 1st long-acting HIV drug combo

It's expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy. Not long ago, patients had to take multiple pills several times a day to control infection with…